Contract awardedDiabetes devices and glucose monitoring supplies

T1D-Plus trial glucose monitors for Cardiff University come from Dexcom

Cardiff University is buying continuous glucose monitoring devices from Dexcom for T1D-Plus, a trial in adults newly diagnosed with type 1 diabetes.

The university sponsors the randomised platform trial, which runs across several centres. Funded by JDRF, it began on 30 September 2022. The Helmsley Charitable Trust and JDRF Australia have since funded extra arms through their own grants. Glucose readings from a monitoring device are one of the trial's endpoints, and the devices on the market vary in specification.

The university awarded the £76,000 contract directly. It runs from January 2026 to January 2027.

Alert me to similar tenders

Contract ends January 2027

What
Diabetes devices and glucose monitoring supplies
Supplier
Dexcom
Value
£76,000
How it was bought
Direct
Dates and next
Jan 2026 to Jan 2027

How it was bought

2 official notices
  1. 19 Jan 2026Award noticeFind a Tender
  2. 19 Jan 2026Award noticeFind a Tender
  3. 20 Jan 2026Contract starts
  4. 20 Jan 2027Contract ends

How it compares

With every diabetes devices and glucose monitoring supplies award since 2021

Half of awards fall between £42,000 and £500,000Median £160,000

Awards
94
Firms that won them
16
Median award
£160,000
of 93 with a value
This award
Smaller than 65%
of them
Typical length
1.5 years
In Wales
2 awards

Dexcom ranks 3rd of 16 firms for diabetes devices and glucose monitoring supplies awards since 2021.

RankFirmAwardsValue
1Locked27£28.9m
2Locked20£15.3m
3Dexcom Won this one16£16.5m
4Locked15£4.53m
5Locked14£4.31m
6Locked10£732,784
See who wins this work

Figures to 21 November 2026

Diabetes devices and glucose monitoring supplies at other buyers

Cardiff University has awarded 485 contracts since 2021.

See Cardiff University's page
  • Dexcom has won 16 public contracts since 2021.